INTERACTIONS BETWEEN 6-MERCAPTOPURINE THERAPY AND THIOPURINE-METHYL-TRANSFERASE (TPMT) ACTIVITY - REPLY

被引：0
|
作者：
CAPDEVILLE, R
MOUSSON, B
BAX, G
机构：
来源：
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1995年 / 48卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
下载
收藏
页码：87 / 88
页数：2
相关论文
共 50 条
  • [1] INTERACTIONS BETWEEN 6-MERCAPTOPURINE THERAPY AND THIOPURINE-METHYL-TRANSFERASE (TPMT) ACTIVITY
    CAPDEVILLE, R
    MOUSSON, B
    BAX, G
    BERTRAND, Y
    PHILIPPE, N
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 46 (04) : 385 - 386
  • [2] COMMENTARY ON INTERACTIONS BETWEEN 6-MERCAPTOPURINE THERAPY AND THIOPURINE-METHYL-TRANSFERASE (TPMT) ACTIVITY
    MCLEOD, HL
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 48 (01) : 85 - 86
  • [3] Individualized therapy with azathioprine or 6-mercaptopurine by monitoring thiopurine methyl-transferase (TPMT) activity
    Gisbert, JP
    Gomollón, F
    Maté, J
    Pajares, JM
    REVISTA CLINICA ESPANOLA, 2002, 202 (10): : 555 - 562
  • [4] Genotype and phenotype analysis of thiopurine-methyl-transferase (TPMT) in a northern Italian
    Daperno, Marco
    Canaparo, Roberto
    Sostegni, Raffaello
    Vemetto, Annalisa
    Serpe, Loredana
    Calvo, Pier L.
    D'Antico, Sergio
    Crocella, Lucia
    Castagno, Franco
    Pera, Angelo
    Zara, Gian Paolo
    Rocca, Rodolfo
    GASTROENTEROLOGY, 2008, 134 (04) : A206 - A206
  • [5] ANALYSIS OF THIOPURINE-METHYL-TRANSFERASE (TPMT) GENOTYPE AND PHENOTYPE IN A NORTHERN ITALIAN POPULATION
    Vernetto, A.
    Sostegni, R.
    Canaparo, R.
    Daperno, M.
    Serpe, L.
    Calvo, P. L.
    D'Antico, S.
    Castagno, F.
    Pera, A.
    Zara, G. P.
    Rocca, R.
    DIGESTIVE AND LIVER DISEASE, 2008, 40 : S130 - S130
  • [6] Thiopurine Methyl Transferase (TPMT) Activity and Erythrocyte Thioguanine Nucleotide Levels Are Reliable Markers of Tolerability to 6-Mercaptopurine in Adult Acute Lymphoblastic Leukemia
    Sengar, Manju
    Gurjar, Murari
    Patil, Anand
    Gota, Vikram
    Jain, Hasmukh
    Menon, Hari
    Dangi, Uma
    BLOOD, 2015, 126 (23)
  • [7] Mesalamine does not impact on thiopurine-methyl-transferase (TPMT) activity in inflammatory bowel disease (IBD) patients
    Daperno, Marco
    Sostegni, Raffaello
    Canaparo, Roberto
    Vernetto, Annalisa
    Serpe, Loredana
    Blanco, Ilenia
    Barbera, Cristiana
    D'Antico, Sergio
    Pera, Angelo
    Zara, Gian Paolo
    Rocca, Rodolfo
    GASTROENTEROLOGY, 2008, 134 (04) : A205 - A206
  • [8] THIOPURINE-METHYL-TRANSFERASE (TPMT) ACTIVITY IN INFLAMMATORY BOWEL DISEASE (IBD) PATIENTS IS NOT AFFECTED BY CO-ADMINISTRATION OF SALYCILATES
    Sostegni, R.
    Canaparo, R.
    Vernetto, A.
    Daperno, M.
    Serpe, L.
    Barbera, C.
    D'Antico, S.
    Blanco, I.
    Pera, A.
    Zara, G. P.
    Rocca, R.
    DIGESTIVE AND LIVER DISEASE, 2008, 40 : S70 - S70
  • [9] Tolerance of thiopurine therapy in patients with intermediate thiopurine S-methyl transferase (TPMT) activity.
    Lewing, K
    Gaedigk, A
    Woods, G
    Gamis, A
    Watanabe, M
    Rothberg, P
    Kearns, G
    Leeder, JS
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 176 - 176
  • [10] Absolute leukocyte count and its correlation with thiopurine methyl transferase (TPMT) activity in inflammatory bowel disease (IBD) patients receiving AZAthioprine (Aza)/6-mercaptopurine (6MP)
    Qasim, A
    Molley, C
    McLoughlin, R
    Sebastian, S
    Buckley, M
    O'Connor, H
    O'Morain, CA
    GASTROENTEROLOGY, 2003, 124 (04) : A204 - A204
12345